Naftopidil has been investigated for the treatment of Disorder of Urinary Stent.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Apixaban | The risk or severity of adverse effects can be increased when Naftopidil is combined with Apixaban. |
| Dasatinib | Dasatinib may increase the anticoagulant activities of Naftopidil. |
| Ursodeoxycholic acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Ursodeoxycholic acid. |
| Glycochenodeoxycholic Acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Glycochenodeoxycholic Acid. |
| Cholic Acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Cholic Acid. |
| Glycocholic acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Glycocholic acid. |
| Deoxycholic acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Deoxycholic acid. |
| Taurocholic acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Taurocholic acid. |
| Obeticholic acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Obeticholic acid. |
| Chenodeoxycholic acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Chenodeoxycholic acid. |
| Taurochenodeoxycholic acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Taurochenodeoxycholic acid. |
| Tauroursodeoxycholic acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Tauroursodeoxycholic acid. |
| Bamet-UD2 | The risk or severity of adverse effects can be increased when Naftopidil is combined with Bamet-UD2. |
| Dehydrocholic acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Dehydrocholic acid. |
| Hyodeoxycholic Acid | The risk or severity of adverse effects can be increased when Naftopidil is combined with Hyodeoxycholic Acid. |
| Glucosamine | Glucosamine may increase the antiplatelet activities of Naftopidil. |
| Ibritumomab tiuxetan | The risk or severity of adverse effects can be increased when Naftopidil is combined with Ibritumomab tiuxetan. |
| Ibrutinib | The risk or severity of adverse effects can be increased when Ibrutinib is combined with Naftopidil. |
| Obinutuzumab | The risk or severity of adverse effects can be increased when Naftopidil is combined with Obinutuzumab. |
| Rivaroxaban | Naftopidil may increase the anticoagulant activities of Rivaroxaban. |
| Tipranavir | Tipranavir may increase the antiplatelet activities of Naftopidil. |
| Urokinase | Naftopidil may increase the anticoagulant activities of Urokinase. |
| Vitamin E | Vitamin E may increase the antiplatelet activities of Naftopidil. |
| Ceritinib | Naftopidil may increase the bradycardic activities of Ceritinib. |
| Ivabradine | Naftopidil may increase the bradycardic activities of Ivabradine. |
| Ruxolitinib | Ruxolitinib may increase the bradycardic activities of Naftopidil. |
| Amifostine | Naftopidil may increase the hypotensive activities of Amifostine. |
| Diazoxide | Diazoxide may increase the hypotensive activities of Naftopidil. |
| Methylphenidate | Methylphenidate may decrease the antihypertensive activities of Naftopidil. |
| Dexmethylphenidate | Dexmethylphenidate may decrease the antihypertensive activities of Naftopidil. |
| Pentoxifylline | Pentoxifylline may increase the hypotensive activities of Naftopidil. |
| Rituximab | Naftopidil may increase the hypotensive activities of Rituximab. |
| Atomoxetine | Atomoxetine may decrease the antihypertensive activities of Naftopidil. |
| Epicaptopril | Epicaptopril may decrease the antihypertensive activities of Naftopidil. |
| Angiotensin 1-7 | Naftopidil may decrease the antihypertensive activities of Angiotensin 1-7. |
| Reserpine | Naftopidil may decrease the antihypertensive activities of Reserpine. |
| Torasemide | Naftopidil may decrease the antihypertensive activities of Torasemide. |
| Chlorthalidone | Naftopidil may decrease the antihypertensive activities of Chlorthalidone. |
| Minoxidil | Naftopidil may decrease the antihypertensive activities of Minoxidil. |
| Metolazone | Naftopidil may decrease the antihypertensive activities of Metolazone. |
| Dexmedetomidine | Dexmedetomidine may decrease the antihypertensive activities of Naftopidil. |
| Mecamylamine | Naftopidil may decrease the antihypertensive activities of Mecamylamine. |
| Furosemide | Naftopidil may decrease the antihypertensive activities of Furosemide. |
| Isoflurane | Isoflurane may decrease the antihypertensive activities of Naftopidil. |
| Fenoldopam | Naftopidil may decrease the antihypertensive activities of Fenoldopam. |
| Propofol | Propofol may decrease the antihypertensive activities of Naftopidil. |
| Remifentanil | Remifentanil may decrease the antihypertensive activities of Naftopidil. |
| Methyldopa | Naftopidil may decrease the antihypertensive activities of Methyldopa. |
| Desflurane | Desflurane may decrease the antihypertensive activities of Naftopidil. |
| Lofexidine | Lofexidine may decrease the antihypertensive activities of Naftopidil. |
| Isoxsuprine | Isoxsuprine may decrease the antihypertensive activities of Naftopidil. |
| Moxonidine | Moxonidine may decrease the antihypertensive activities of Naftopidil. |
| Dutasteride | Dutasteride may decrease the antihypertensive activities of Naftopidil. |
| Eletriptan | Eletriptan may decrease the antihypertensive activities of Naftopidil. |
| Methysergide | Methysergide may decrease the antihypertensive activities of Naftopidil. |
| Cabergoline | Cabergoline may decrease the antihypertensive activities of Naftopidil. |
| Methylergometrine | Methylergometrine may decrease the antihypertensive activities of Naftopidil. |
| Mirtazapine | Mirtazapine may decrease the antihypertensive activities of Naftopidil. |
| Buspirone | Buspirone may decrease the antihypertensive activities of Naftopidil. |
| Lisuride | Lisuride may decrease the antihypertensive activities of Naftopidil. |
| Sufentanil | Sufentanil may decrease the antihypertensive activities of Naftopidil. |
| Alfentanil | Alfentanil may decrease the antihypertensive activities of Naftopidil. |
| Fentanyl | Fentanyl may decrease the antihypertensive activities of Naftopidil. |
| Almotriptan | Almotriptan may decrease the antihypertensive activities of Naftopidil. |
| Salmeterol | Salmeterol may decrease the antihypertensive activities of Naftopidil. |
| Albuterol | Salbutamol may decrease the antihypertensive activities of Naftopidil. |
| Guanfacine | Guanfacine may decrease the antihypertensive activities of Naftopidil. |
| Methoxyflurane | Methoxyflurane may decrease the antihypertensive activities of Naftopidil. |
| Ergoloid mesylate | Ergoloid mesylate may decrease the antihypertensive activities of Naftopidil. |
| Desipramine | Desipramine may decrease the antihypertensive activities of Naftopidil. |
| Halothane | Halothane may decrease the antihypertensive activities of Naftopidil. |
| Pergolide | Pergolide may decrease the antihypertensive activities of Naftopidil. |
| Finasteride | Finasteride may decrease the antihypertensive activities of Naftopidil. |
| Clomipramine | Clomipramine may decrease the antihypertensive activities of Naftopidil. |
| Ergometrine | Ergometrine may decrease the antihypertensive activities of Naftopidil. |
| Yohimbine | Yohimbine may decrease the antihypertensive activities of Naftopidil. |
| Solifenacin | Solifenacin may decrease the antihypertensive activities of Naftopidil. |
| Lysergic acid diethylamide | Lysergic acid diethylamide may decrease the antihypertensive activities of Naftopidil. |
| Flibanserin | Flibanserin may decrease the antihypertensive activities of Naftopidil. |
| Indacaterol | Indacaterol may decrease the antihypertensive activities of Naftopidil. |
| Rotigotine | Rotigotine may decrease the antihypertensive activities of Naftopidil. |
| Cariprazine | Cariprazine may decrease the antihypertensive activities of Naftopidil. |
| Mianserin | Mianserin may decrease the antihypertensive activities of Naftopidil. |
| Vilazodone | Vilazodone may decrease the antihypertensive activities of Naftopidil. |
| Lurasidone | Lurasidone may decrease the antihypertensive activities of Naftopidil. |
| Mirabegron | Mirabegron may decrease the antihypertensive activities of Naftopidil. |
| Cannabidiol | Cannabidiol may decrease the antihypertensive activities of Naftopidil. |
| Vilanterol | Vilanterol may decrease the antihypertensive activities of Naftopidil. |
| Tianeptine | Tianeptine may decrease the antihypertensive activities of Naftopidil. |
| Dihydroergocornine | Dihydroergocornine may decrease the antihypertensive activities of Naftopidil. |
| Bosentan | Naftopidil may decrease the antihypertensive activities of Bosentan. |
| Guanethidine | Naftopidil may decrease the antihypertensive activities of Guanethidine. |
| Hydralazine | Naftopidil may decrease the antihypertensive activities of Hydralazine. |
| Sitaxentan | Naftopidil may decrease the antihypertensive activities of Sitaxentan. |
| Ambrisentan | Naftopidil may decrease the antihypertensive activities of Ambrisentan. |
| Pinacidil | Naftopidil may decrease the antihypertensive activities of Pinacidil. |
| Riociguat | Naftopidil may decrease the antihypertensive activities of Riociguat. |
| Macitentan | Naftopidil may decrease the antihypertensive activities of Macitentan. |
| Selexipag | Naftopidil may decrease the antihypertensive activities of Selexipag. |
| Siponimod | Siponimod may decrease the antihypertensive activities of Naftopidil. |